FindTrial
Sign In

Clinical diagnosis and treatment, maternal and infant outcomes of hyperbilirubinemia in pregancy:?a retrospective study based on medical records

Clinical diagnosis and treatment, maternal and infant outcomes of hyperbilirubinemia in pregancy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031994
Enrollment
Unknown
Registered
2020-04-17
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperbilirubinemia

Interventions

case series:N/A

Sponsors

Women's Hospital, Medical School of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Pregnant women with hypercholesterolemia (TBA > = 10umol / L) delivered from January 1, 2019 to December 31, 2019 in women's hospital, Medical School of Zhejiang University.

Exclusion criteria

Exclusion criteria: Incomplete medical records / missing follow-up.

Design outcomes

Primary

MeasureTime frame
Laboratory indicators;Imaging index;;Follow up outcome;—

Secondary

MeasureTime frame
General Information;—

Countries

China

Contacts

Public ContactBai Xiaoxia

Women's Hospital, Medical School of Zhejiang University

baixiaoxia@zju.edu.cn+86 13957152365

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026